News | April 26, 2023
Siegfried breaks ground on new R&D center for drug substances in Switzerland
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
Biocon Biologics Limited will have access to 100 million doses of vaccines annually together with the distribution rights to Serum's Vaccine portfolio
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
Apollo continues to invest in genomics technology and research for better patient care
The New State-of-Art OligoPilot 2000 solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
The USFDA had classified the inspection as "Official Action Indicated" (OAI).
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
Fully equipped labs with 75-member team set-up and made operational in <100 days
Subscribe To Our Newsletter & Stay Updated
